Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-14-307669
Filing Date
2014-08-13
Accepted
2014-08-13 09:35:53
Documents
10
Period of Report
2014-06-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q d756432d10q.htm 10-Q 520790
2 EX-31.1 d756432dex311.htm EX-31.1 6044
3 EX-31.2 d756432dex312.htm EX-31.2 6055
4 EX-32.1 d756432dex321.htm EX-32.1 3381
  Complete submission text file 0001193125-14-307669.txt   2998685

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE DOCUMENT epzm-20140630.xml EX-101.INS 343212
6 XBRL TAXONOMY EXTENSION SCHEMA epzm-20140630.xsd EX-101.SCH 31200
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE epzm-20140630_cal.xml EX-101.CAL 40678
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE epzm-20140630_def.xml EX-101.DEF 56266
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE epzm-20140630_lab.xml EX-101.LAB 255143
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE epzm-20140630_pre.xml EX-101.PRE 161927
Mailing Address 400 TECHNOLOGY SQUARE 4TH FLOOR CAMBRIDGE MA 02139
Business Address 400 TECHNOLOGY SQUARE 4TH FLOOR CAMBRIDGE MA 02139 617-229-5872
Epizyme, Inc. (Filer) CIK: 0001571498 (see all company filings)

EIN.: 261349956 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-35945 | Film No.: 141035926
SIC: 2834 Pharmaceutical Preparations